The interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells has been identified as an important mechanism of immune evasion of tumor cells with high PD-1 expression consequently leading to depleted antitumor immune responses (reviewed by Zhang et al., 2017). The gene discussed is PDCD1; the disease is neoplasm.